share_log

Wedbush Cuts Beam Therapeutics' Price Target to $100 From $152, Citing Liver Programs Timeline, Lowered Ramp for BEAM-101; Outperform Rating Kept

Wedbush Cuts Beam Therapeutics' Price Target to $100 From $152, Citing Liver Programs Timeline, Lowered Ramp for BEAM-101; Outperform Rating Kept

韋德布什將BEAM Treateutics的目標價從152美元下調至100美元，理由是肝臟計劃時間表，下調了BEAM-101的斜率；保持跑贏評級
MT Newswires ·  2022/05/10 16:49

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文
登入/註冊

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論